Ontario Teachers Pension Plan Board lifted its stake in shares of Cabot Co. (NYSE:CBT - Free Report) by 105.2% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 21,623 shares of the specialty chemicals company's stock after acquiring an additional 11,084 shares during the period. Ontario Teachers Pension Plan Board's holdings in Cabot were worth $1,974,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Orion Portfolio Solutions LLC purchased a new position in shares of Cabot during the 3rd quarter valued at about $609,000. MML Investors Services LLC lifted its holdings in shares of Cabot by 6.5% in the 3rd quarter. MML Investors Services LLC now owns 6,358 shares of the specialty chemicals company's stock worth $711,000 after acquiring an additional 389 shares during the last quarter. Public Employees Retirement System of Ohio boosted its stake in shares of Cabot by 170.2% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 2,351 shares of the specialty chemicals company's stock valued at $263,000 after purchasing an additional 1,481 shares in the last quarter. Barclays PLC grew its holdings in shares of Cabot by 103.9% during the 3rd quarter. Barclays PLC now owns 113,614 shares of the specialty chemicals company's stock valued at $12,699,000 after purchasing an additional 57,907 shares during the last quarter. Finally, Geode Capital Management LLC raised its position in Cabot by 1.8% in the 3rd quarter. Geode Capital Management LLC now owns 1,283,686 shares of the specialty chemicals company's stock worth $143,504,000 after purchasing an additional 22,719 shares during the period. 93.18% of the stock is currently owned by hedge funds and other institutional investors.
Cabot Trading Up 0.1 %
Shares of NYSE CBT traded up $0.08 during trading hours on Friday, hitting $78.40. The company's stock had a trading volume of 338,411 shares, compared to its average volume of 387,326. Cabot Co. has a 12 month low of $73.63 and a 12 month high of $117.46. The stock has a market cap of $4.25 billion, a price-to-earnings ratio of 10.41, a P/E/G ratio of 0.74 and a beta of 1.04. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.29 and a current ratio of 2.00. The business has a 50-day simple moving average of $82.71 and a 200-day simple moving average of $94.90.
Cabot (NYSE:CBT - Get Free Report) last issued its quarterly earnings data on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share for the quarter, topping analysts' consensus estimates of $1.74 by $0.02. Cabot had a return on equity of 26.79% and a net margin of 10.60%. On average, analysts anticipate that Cabot Co. will post 7.57 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Several analysts have issued reports on CBT shares. UBS Group cut their price target on shares of Cabot from $93.00 to $83.00 and set a "neutral" rating for the company in a research report on Monday, April 7th. StockNews.com raised Cabot from a "hold" rating to a "buy" rating in a research note on Thursday. JPMorgan Chase & Co. dropped their price objective on Cabot from $105.00 to $85.00 and set an "underweight" rating for the company in a research note on Friday, February 21st. Finally, Mizuho cut their target price on shares of Cabot from $122.00 to $110.00 and set an "outperform" rating on the stock in a report on Tuesday, January 7th.
Read Our Latest Analysis on CBT
About Cabot
(
Free Report)
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Further Reading

Before you consider Cabot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.
While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.